-
公开(公告)号:EP2457895A1
公开(公告)日:2012-05-30
申请号:EP11184396.7
申请日:2005-07-12
发明人: Chao, Bin , Deckwerth, Thomas L. , Furth, Paul S. , Linton, Steven D. , Spada, Alfred P. , Ullman, Brett R. , Weinhouse, Michael I.
IPC分类号: C07D207/16 , C07D207/22 , C07D209/42 , C07D209/44 , C07D211/76 , C07D213/64 , C07D233/10 , C07D263/06 , C07D277/06 , C07D487/04 , C07D487/06 , C07D513/04 , C07K5/06 , C07K5/08 , C07K5/10 , C07D207/273 , C07D207/24 , A61P35/00 , A61K31/401 , A61K38/06
CPC分类号: C07D207/16 , A61K38/00 , C07D207/22 , C07D207/24 , C07D207/273 , C07D209/42 , C07D209/44 , C07D211/76 , C07D213/64 , C07D233/10 , C07D263/06 , C07D277/06 , C07D487/04 , C07D487/06 , C07D513/04 , C07K5/06026 , C07K5/0806 , C07K5/1008 , Y02A50/411 , Y02A50/414
摘要: Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer are provided.
or a pharmaceutically acceptable salt thereof, where:
M is CO, SO or SO 2 ;
W1 is a 5-7 membered heterocyclic or heteroaryl ring containing 1 or 2 heteroatoms.
The other variables are as defined in the claims.摘要翻译: 提供了用于治疗过度增殖性疾病如癌症的化合物,组合物和方法。 或其药学上可接受的盐,其中:M是CO,SO或SO 2; W1是含有1或2个杂原子的5-7元杂环或杂芳基环。 其他变量如权利要求中所定义。